Article Versions Notes

Tetar SU, Bohoudi O, Senan S, Palacios MA, Oei SS, Wel AMvd, Slotman BJ, Moorselaar RJAv, Lagerwaard FJ, Bruynzeel AME. The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer. Cancers. 2020; 12(10):2763. https://doi.org/10.3390/cancers12102763

Tetar, Shyama U., Omar Bohoudi, Suresh Senan, Miguel A. Palacios, Swie S. Oei, Antoinet M. van der Wel, Berend J. Slotman, R. Jeroen A. van Moorselaar, Frank J. Lagerwaard, and Anna M. E. Bruynzeel. 2020. "The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer" Cancers 12, no. 10: 2763. https://doi.org/10.3390/cancers12102763

Tetar, S. U., Bohoudi, O., Senan, S., Palacios, M. A., Oei, S. S., Wel, A. M. v. d., Slotman, B. J., Moorselaar, R. J. A. v., Lagerwaard, F. J., & Bruynzeel, A. M. E. (2020). The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer. Cancers, 12(10), 2763. https://doi.org/10.3390/cancers12102763